• SURMOUNT-OSA investigators will unveil new findings in obesity-related OSA

    SURMOUNT-OSA investigators will unveil new findings in obesity-related OSA

    Atul Malhotra, MD, will be among the researchers sharing phase 3 clinical trial data showing the potential of a dual gastric inhibitory polypeptide (GIP) and glucagon‐like peptide‐1 (GLP‐1) receptor agonist used in the treatment of type 2 diabetes as a potential therapy for obesity-related obstructive sleep apnea (OSA). SURMOUNT-OSA evaluated how tirzepatide injection affected the…





  • Presenter Profiles: Liver Health in Diabetes

    Presenter Profiles: Liver Health in Diabetes

    Kenneth Cusi, MD, and Karen D. Corbin, PhD, RD, preview a presentation at the 84th Scientific Sessions. Attendees in Orlando can watch the session in-person Friday, June 21, at 5:30 p.m. ET, and select recordings will be available on the meeting’s virtual platform after the live presentations.

  • Presenter Profile:  Consensus or Controversy? Hot Topics in Nutrition 2024

    Presenter Profile: Consensus or Controversy? Hot Topics in Nutrition 2024

    Katherine Appleton, PhD, RNutr, previews a presentation at the 84th Scientific Sessions. Attendees in Orlando can watch the session in-person Friday, June 21, at 3:45 p.m. ET, and select recordings will be available on the meeting’s virtual platform after the live presentations.

  • Presenter Profile:  Diabetic Retinopathy Care and Screening—Is Artificial Intelligence Changing the Future?

    Presenter Profile: Diabetic Retinopathy Care and Screening—Is Artificial Intelligence Changing the Future?

    Aaron Y. Lee, MD, MSCI, previews a presentation at the 84th Scientific Sessions. Attendees in Orlando can watch the session in-person Saturday, June 22, at 3:15 p.m. ET, and select recordings will be available on the meeting’s virtual platform after the live presentations.